MELISSA MOYER: Open Payments
NPI 1457724411 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 19 payments from 6 companies in 2025. Trend: 2023 $615 · 2024 $873 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $238 |
| ABBVIE INC. | 2 | $149 |
| Abbott Laboratories | 2 | $124 |
| EVOKE PHARMA, INC. | 1 | $100 |
| PFIZER INC. | 2 | $34 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
Products named: QULIPTA, FREESTYLE LIBRE 3, GIMOTI, Ozempic, Wegovy, UBRELVY, NEFFY, PREVNAR 20.
Industry payments across MI — which companies pay providers there.
